Categories: All postsBlackBerry

BlackBerry has been our biggest dog, this fund manager says

With its share price continuing to trail off, it’s now a wait-and-see game for BlackBerry (BlackBerry News, Stock Quote, Chart TSX:BB), says portfolio manager Keith Richards, who claims the stock could plummet if it breaks through a key support level.

BlackBerry’s 2019 started off very well, with the stock gaining a full 40 per cent over the first three months, but since then it’s been mostly downhill, as all of those gains have now been erased and the stock looks about set to test a support level at C$9.00. Below that could be a significant plunge, says Richards of ValueTrend Wealth Management, who spoke to BNN Bloomberg on Tuesday.

“We own this stock, unfortunately. It’s been our single biggest dog,” Richards says. “There has been this really long, maybe five-year pattern but it is holding its last low.”

“It’s precarious. If it breaks, I will be out of the trade, but for now I’m in,” he says. “I’m underwater on it and I’m trying to be disciplined on this stuff. If it breaks, it breaks and I just say goodbye, but I’m giving it the benefit of the doubt because it has bounced off of these levels before. We’ll see what happens.”

BlackBerry has been roundly praised for its transformation from phone maker to software and security company but questions remain about revenue growth, with the company’s latest quarterly results coming as a prime example. While BB beat analysts’ estimates on adjusted revenue for its fiscal first quarter, coming in with a $267-million top line which was better than the expected $265 million, the company’s share price fell sharply with the quarterly release, nonetheless. (All figures in US dollars unless noted otherwise.)

The drop in share price was reportedly attributed to concerns over competition along with seemingly underwhelming results from Cylance, BlackBerry’s cybersecurity subsidiary, which brought in $32 million in GAAP revenue for the quarter.

More Cantech BlackBerry

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: bb
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

17 mins ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

53 mins ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

15 hours ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

1 day ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

1 day ago

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

2 days ago